Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $386.11 -0.46%
Revenue Growth %: -0.3%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
